Home - Lyell
bm-navigation: bm-t3-home-navigation
bm-hero: homepage-hero

Curative cell-based immunotherapies for human disease

bm-basic: home-about

ABOUT

Lyell Immunopharma Inc. is a cellular therapy company dedicated to mastering immune cell functionality. We are focused on advancing the science of t-cell differentiation, functionality, and specificity so that we can develop curative treatments for human disease. We are all about the cells.

bm-grid: home-founders

FOUNDERS

Our founders are pioneers in CAR-T therapy and protein engineering. They have spent decades developing science in the immunotherapy and protein engineering fields, generating original insights that have put them at the cutting edge of research and drug development.  At Lyell, they do more than advise—they work directly and intensively with the company to design, develop, test and launch the next generation of cell-based immunotherapies.

Together, their insights and expertise will help Lyell create CAR-T cells that overcome the obstacles to efficacy in solid cancers.

Rick Klausner, MD

Founder & CEO

Stan Riddell, MD

Founder

Crystal Mackall, MD

Founder

David Baker, PhD

Founder

TEAM

Our team is comprised of world-class leaders and scientists united by one mission: to develop highly selective, curative cell-based immunotherapies.

VIEW TEAM
bm-grid: home-news-grid

NEWS

Press Releases

View our company announcements

Read More

Publications

Read relevant journal articles and white papers

Read More

News

Catch up on the latest news

Read More
VIEW ALL

CAREERS

Help us cure cancer. Join the team.

VIEW CAREERS
bm-grid: home-contact-grid

CONTACT

SAN FRANCISCO

400 East Jamie Court
Suite 301
South San Francisco, CA
94080

SEATTLE

500 Fairview Avenue N
Suite 560
Seattle, WA
98109